Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Mount Sinai Hospital
1468 Madison AvenueAnnenberg Building, 4th Floor
New York, New York, United States
Phone Web
In addition to dedicated treatment programs in hemophilia, sickle cell disease, and thrombophilia, our physicians provide care to children with anemia secondary to hemoglobinopathy, red cell membrane or enzyme disorders, aplastic anemia (including Fanconi’s anemia), thrombocytopenia (also known as ITP), neutropenia, polycythemia, and thrombocytosis.
Hematological conditions treated here include:
-Sickle cell disease
-Hemoglobinopathies
-Anemia
-Congenital and acquired thrombocytopenia including ITP
-Bleeding and clotting disorders
Our pediatric hematologists have been delivering state-of-the-art care to all patients with sickle cell disease for several decades. Basic research at Mount Sinai has included gene therapy for hemoglobinopathy, studies on cell interactions that lead to the excessive adhesion of red cells and enhancement of fetal hemoglobin to minimize the symptoms of sickle cell disease. The Sickle Cell Program here is a comprehensive program designed to provide holistic care. Patients have access to social workers, genetic counselors, cardiologists, pulmonologists, neurologists, and psychologists. Together with the experienced Pediatric Intensive Care Unit staff, the hospital treats the most life threatening complications such as stroke and acute chest syndrome. The blood bank provides accessibility to hemopheresis for emergencies.
Related Content
-
Edward J. Benz Jr., MDDr. Benz graduated from Harvard Medical ...
-
Genice Nelson, DNP, APRN, ANP-BCDr. Genice Nelson is a Nurse Practitione...
-
University of North Carolina at Chapel Hill School of Medicine, Division of Hematology/OncologyThe Division of Hematology/Oncology offe...
-
2019 WEPSCF Rockin’ the Red – 14th Annual FundraiserJoin us as we celebrate National Sickle ...
-
Providing Expert Care for Pregnant Sickle Cell Patienthttps://www.youtube.com/watch?v=rTebitxq...
-
The Affordable Care Act Improves Healthcare Access and Utilization Among Young Adults with Sickle Cell DiseaseIntroduction: The Dependent Coverage Pro...
-
Hydroxyurea effectiveness in children and adolescents with sickle cell anemia: A large retrospective, population-bas...The clinical efficacy of hydroxyurea in ...
+myBinder